Inclusion Criteria:

• Male or female, aged 18 years or above
• Participants who have an estimated glomerular filtration rate between 15 and 45 ml/min/1.73m2
• Serum potassium concentration between 4.5 and 5.5 milliequivalent (mEq)/L
• Hemoglobin A1c ≤ 11%
• Systolic and diastolic blood pressure <160/100 mmHg
• Are registered in the multidisciplinary nephrology clinic in Winnipeg
• Able to communicate in English and provide written informed consent

Exclusion Criteria:

• Serum potassium concentration > 5.6 mEq/L, anuria, dialysis, or acute kidney injury failure in the 6 months prior to screening
• Chronic obstructive pulmonary disease that requires the participant to be on oxygen
• New York Heart Association Class 3-4 Heart symptoms or heart, liver or renal transplant
• A myocardial infarction or stroke within the last 6 months
• Unable to consume study treatments or control, such as swallowing or gastro-intestinal issues
• Currently on potassium binding therapy
• In the opinion of the investigator any medical condition, uncontrolled systemic disease or concurrent illness that would decrease the study compliance or jeopardize the safety of the participant
• Female participant who is pregnant or lactating